"Among the aims of the research team is to better understand whether gene therapy may one day provide a different approach to ...
Memory care can help people with dementia live longer and better. Here’s what to expect before moving your loved one in.
Doctors say clinical trials are needed to understand more after Ed Patrick identified a potential side effect of a ...
Tavapadon, a treatment for Parkinson’s disease recently approved by the FDA, provides a novel option for healthcare providers ...
Potent sedating medications are often used on agitated people with dementia in long-term care facilities despite federal ...
The caregiver accused of hiding the death of a Baltimore woman's father​ and taking control of his finances has been arrested ...
At the "Student Day" held every Wednesday at TIB by TIB JAM, students who want to challenge themselves with entrepreneurship ...
The FDA has approved Juvmo, an oral tavapadon treatment for adults with Parkinson’s disease, following three pivotal phase 3 ...
The Food and Drug Administration (FDA) recently approved a first-of-its-kind medication for treating Parkinson’s disease. Patients take JUVMO daily, a prescription medication that mimics the ...
People living with Parkinson’s disease are hospitalized more often than other older adults, most often because of infections, falls, fractures, or other medical problems rather than Parkinson’s itself ...
"The investigator arrived exactly when my husband's midday medication was working. He stood up from his chair smoothly and ...
AbbVie announced that the U.S. Food and Drug Administration (FDA) has approved JUVMO (tavapadon) tablets as the first and only selective D1/D5 receptor agonist for the treatment of adults with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results